Skip to main content

Table 3 Prevalence for HERV-K113 and HERV-K115 in different populations

From: Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy

Population

Total samples

HERV-K113+ (%)

HERV-K115+ (%)

HERV-K113+ (%)

VBD

30

2(7)

6(20)

8(27)

LGLL

3

1(33)

0(0)

1(33)

HTVLt

24

0(0)

4(17)

4(17)

HTVLm

13

0(0)

1(8)

1(8)

HTVLn

11

0(0)

3(27)

3(27)

MS

24

4(17)

4(17)

8(33)